Search

Bovine brucellosis (BB) is a cosmopolitan zoonotic disease caused by certain bacteria of the genus Brucella. It has negative health implications for the cattle, economic implications for the owners and is present in numerous cattle and wildlife populations worldwide. To determine the seroprevalence of BB in dual-purpose herds and assess its impact in the southern part of the Department of Atlántico, northern Colombia. 1,000 female cattle were tested for brucellosis, using the Rose Bengal Plate Test (RBPT) and indirect ELISA (iELISA) as screening and confirmatory tests, respectively. Of these, 100 animals tested positive by RBPT and 204 were inconclusive, while 38 positive animals were identified by iELISA. Consequently, the apparent seroprevalence was 3.8%, and the estimated true prevalence was 4.4%. Based on estimates of the economic losses caused by BB, the cost was calculated at $2,496,364 COP ($822 USD) per animal. The costs identified in this study include medication costs, loss of lactation, and others. It highlights the significant impact of BB on food security, particularly concerning the availability of and access to bovine food products, as well as on the economy of livestock farmers in the region., Competing Interests: Declarations. Ethics approval: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The study was approved by the Ethics Committee of the Universidad del Atlántico, under code 26-08-2016. Consent to participate: Informed consent was obtained from all individual participants included in the study. Consent to publish: All authors agree for publication. Competing interests: The authors declare no competing interests., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)

Multivalent live-attenuated or inactivated vaccines are often used to control the bovine viral diarrhea disease (BVD). Still, they retain inherent disadvantages and do not provide the expected protection. This study developed a new vaccine prototype, including the external segment of the E2 viral protein from five different subgenotypes selected after a massive screening. The E2 proteins of every subgenotype (1aE2, 1bE2, 1cE2, 1dE2, and 1eE2) were produced in mammalian cells and purified by IMAC. An equimolar mixture of E2 proteins formulated in an oil-in-water adjuvant made up the vaccine candidate, inducing a high humoral response at 50, 100, and 150 µg doses in sheep. A similar immune response was observed in bovines at 50 µg. The cellular response showed a significant increase in the transcript levels of relevant Th1 cytokines, while those corresponding to the Th2 cytokine IL-4 and the negative control were similar. High levels of neutralizing antibodies against the subgenotype BVDV1a demonstrated the effectiveness of our vaccine candidate, similar to that observed in the sera of animals vaccinated with the commercial vaccine. These results suggest that our vaccine prototype could become an effective recombinant vaccine against the BVD.

Previously, we designed a subunit vaccine candidate based on three L. intracellularis antigens with promising results in pigs. In this study, antigens were produced individually to achieve an even antigen ratio in the formulation. The emulsion characterization included the drop size and the mechanical and thermal stability. Immune response was evaluated by indirect and sandwich ELISAs, qPCR, and flow cytometry. The vaccine candidate's safety was assessed by histopathology and monitoring the clinical behavior of animals. The average production yielded for the chimeric antigen as inclusion bodies was around 75 mg/L. The formulation showed mechanical and thermal stability, with a ratio Hu/Ho > 0.85 and a drop size under 0.15 nm. Antigens formulated at a ratio of 1:1:1 induced a significant immune response in inoculated pigs that persisted until the end of the experiment (week 14). The dose of 200 μg significantly activated cellular response measured by transcriptional and translational levels of cytokines. The cell proliferation assay revealed an increment of lymphocytes T CD4 + at the same dose. Animals gained weight constantly and showed proper clinical behavior during immunization assays. This research demonstrated the immunological robustness of the new subunit vaccine candidate against Porcine Proliferative Enteropathy evenly formulated with three chimeric antigens of L. intracellularis .

Echinococcosis is a neglected zoonosis that uses dogs and sheep as its main hosts in Chile. The Eg95 vaccine against sheep infection has been included in some control programs. Here, we assess the efficacy of the vaccination program in the hyperendemic Alto Biobío commune after 3 years of execution. Fisher’s test and generalized linear models were used in the assessment. The program tried to offer a first dose at 2 months of age, a booster 1 month later, and yearly vaccination. Given logistic difficulties, important delays in vaccination occurred, and most animals did not receive the first booster. Dog deworming was not included in the program. Likely due to the aforementioned factors, the overall frequency of infection was not lower, but the proportion of large (>5 mm) cysts and fertile cysts was smaller after the program. The frequency of infection and/or the number of cysts were lower when the age at first dose was younger and the first booster was administered 1 month after the first dose. The results suggest that vaccination affects both cyst development after the larvae reach the target organs, as well as the development of the protoscolex once the cysts start developing.

The objectives of this study were (1) to estimate the frequency and dynamics of bovine abortion syndrome; (2) to identify groups of cows affected by abortion; and (3) to assess the characteristics of herd management and lactation associated with abortion rates. The study was performed using farmers' historical records for 77 dairy herds in the south of Chile (Bio-Bio, Los Lagos and Los Ríos Regions) collected between 2001 and 2005. These records included 44,959 lactations from 20,977 cows. In addition, farm management practices were assessed through a questionnaire involving 127 herds. The herds were selected according to the farmers' willingness to participate and the existence of high-quality electronic records assessed by the practitioners advising the farms. The frequency distribution of observed, inferred and general abortions was estimated by the incidence rate (IR). A hierarchical logistic regression analysis with random intercept was performed to assess the association between herd management and lactation characteristics and the occurrence of abortion. An IR of 1.74 per 100 cow-months at risk was estimated. General abortions were highest in first-parity cows (IR: 1.85 per 100 cow-months at risk). Abortion cases inferred from individual records were most frequent in the first trimester of gestation and decreased over time, whereas observed abortions increased in accordance with gestation time. The period of highest risk for abortion was around 82 days of gestation. Management practices such as a tap drinking system for cows, a closed herd, vaccination against leptospirosis, exclusive use of pasture for cows, animal density, the time that a calf stays with its dam and breed type were associated with the risk of abortion. The results of this study demonstrate that there is a large underestimation of abortion rates when only farmers' abortion records are analysed, and there are several factors associated with the risk of abortion., (Copyright © 2012 Elsevier B.V. All rights reserved.)